Stuart A. Arbuckle, EVP, COO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 3 shares at $186.99 ($562) on 2021-11-15, disclosed to the SEC on 2021-11-16.
Scheduled sale ($562) by EVP, COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $186.99 | 2 | $374 | 66.6% |
| 2 | $187.80 | 1 | $188 | 33.4% |
| Total | $187.26 avg | 3 | $562 | 100% |
| Filing → |
| VRTX | SELL | 2024-02-23 | $3.0M | — | Filing → |
| VRTX | SELL | 2024-02-21 | $4.0M | — | Filing → |
| VRTX | SELL | 2024-02-13 | $3.6M | — | Filing → |